missing translation for 'onlineSavingsMsg'
Learn More

KIR2DS4/CD158i Antibody (179315), DyLight 405, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals FAB1847E

Product Code. 18078125

  • € 915.00 / 0.50mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

KIR2DS4/CD158i Monoclonal antibody specifically detects KIR2DS4/CD158i in Human samples. It is validated for Western Blot, Flow Cytometry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

KIR2DS4/CD158i
Monoclonal
DyLight 405
CD158 antigen-like family member I, CD158I, CD158i antigen, cl-39, killer cell immunoglobulin-like receptor 2DS4, killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail4,nkat8, killer inhibitory receptor 4-1-2, KIR antigen 2DS4, KKA3KIR1D, MGC120019, MGC125315, MGC125317, MHC class I NK cell receptor, natural killer cell inhibitory receptor, Natural killer-associated transcript 8, NKAT-8, NKAT8KIR412, P58 natural killer cell receptor clones CL-39/CL-17, p58 NK receptor CL-39/CL-17
BaF3 mouse pro-B cell line transfected with human KIR2DS4, Accession # P43632
0.5 mL
Immunology
3809
Store at 4°C in the dark.
IgG2a
Western Blot, Flow Cytometry
179315
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.